4.8 Article

High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Adaptive immunity to SARS-CoV-2 and COVID-19

Alessandro Sette et al.

Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.
Letter Medicine, General & Internal

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Alicia T. Widge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.
Review Virology

Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype

Steve Pascolo

Summary: Synthetic mRNA vaccines have proven to be one of the fastest, safest, and most effective vaccines against SARS-CoV-2; just 30 micrograms of mRNA can generate high levels of neutralizing antibodies in all recipients; the distribution of these vaccines worldwide will help halt the coronavirus pandemic.

VIRUSES-BASEL (2021)

Article Cell Biology

Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans

Henry J. Sutton et al.

Summary: Using single-cell RNA sequencing, researchers explored the diversity of human B cells in healthy individuals and those exposed to malaria, identifying two distinct lineages with atypical B cells being part of the alternative lineage. Upon malaria vaccination, the alternative lineage cells respond to initial immunization and booster doses, but develop an atypical phenotype with repeated boosts, indicating that atypical cells are a normal component of healthy immune responses.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

Catherine J. Reynolds et al.

Summary: Vaccination with a single dose of BNT162b2 after prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants. In contrast, individuals without prior infection showed reduced immunity against variants after receiving a single vaccine dose.

SCIENCE (2021)

Article Immunology

Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination

Rishi R. Goel et al.

Summary: mRNA vaccines exhibit robust serological and cellular priming, with naïve individuals requiring two doses for optimal antibody responses, especially against the B.1.351 variant. Memory B cells specific for spike protein and RBD were efficiently primed by vaccination, while recovered individuals showed significant boosting after the first dose, correlating with preexisting memory B cell levels. Identifying distinct responses based on prior SARS-CoV-2 exposure suggests that recovered subjects may only need one vaccine dose for peak responses, which can inform vaccine distribution strategies in resource-limited settings.

SCIENCE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Zijun Wang et al.

Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.

NATURE (2021)

Article Medicine, Research & Experimental

T-bet+CD27+CD21- B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants

Kevin Louis et al.

Summary: Alloimmune responses driven by donor-specific antibodies can lead to antibody-mediated rejection in organ transplantation. This study identified expanded numbers of activated memory B cells expressing T-bet in patients who developed DSAs and progressed to ABMR. These AM cells were found to be poised for plasma cell differentiation and played a pivotal role in promoting humoral responses and ABMR.

JCI INSIGHT (2021)

Review Critical Care Medicine

Emerging SARS-CoV-2 variants of concern and potential intervention approaches

Jasmin Khateeb et al.

Summary: Mutations in VOCs can increase the transmissibility of the virus and potentially impact vaccine efficacy, highlighting the need for combination therapeutic strategies.

CRITICAL CARE (2021)

Article Medicine, Research & Experimental

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

Alessio Mazzoni et al.

Summary: The study suggests that COVID-19-recovered individuals may not need a second vaccine dose to further enhance immune response, while naive individuals require a second dose for increased immunity. This indicates that redirecting vaccine doses from COVID-19-recovered individuals to naive individuals could shorten the time to achieve herd immunity.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Biochemistry & Molecular Biology

B Cell Responses: Cell Interaction Dynamics and Decisions

Jason G. Cyster et al.

Article Cell Biology

FCRL5+ Memory B Cells Exhibit Robust Recall Responses

Charles C. Kim et al.

CELL REPORTS (2019)

Review Immunology

Generation of memory B cells and their reactivation

Takeshi Inoue et al.

IMMUNOLOGICAL REVIEWS (2018)

Article Multidisciplinary Sciences

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE

Shu Wang et al.

NATURE COMMUNICATIONS (2018)

Article Microbiology

Malaria-induced interferon-γ drives the expansion of Tbet hi atypical memory B cells

Nyamekye Obeng-Adjei et al.

PLOS PATHOGENS (2017)

Review Immunology

Plasma cell and memory B cell differentiation from the germinal center

Dan Suan et al.

CURRENT OPINION IN IMMUNOLOGY (2017)

Review Immunology

Germinal Center B Cell Dynamics

Luka Mesin et al.

IMMUNITY (2016)

Review Oncology

Human memory B cells

M. Seifert et al.

LEUKEMIA (2016)

Article Multidisciplinary Sciences

Apoptosis and antigen affinity limit effector cell differentiation of a single naive B cell

Justin J. Taylor et al.

SCIENCE (2015)

Review Immunology

The generation of antibody-secreting plasma cells

Stephen L. Nutt et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Immunology

Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies

Matthias F. Muellenbeck et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Multidisciplinary Sciences

T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance

Kira Rubtsova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Immunology

A germinal center-independent pathway generates unswitched memory B cells early in the primary response

Justin J. Taylor et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Article Multidisciplinary Sciences

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Jens Wrammert et al.

NATURE (2008)

Review Immunology

Antigen-specific memory B cell development

LJ McHeyzer-Williams et al.

ANNUAL REVIEW OF IMMUNOLOGY (2005)

Article Immunology

Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival

DMY Sze et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2000)